Qian Jiang
Peking University People's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Qian Jiang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:51 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07925190 · A Phase III Study Comparing Mesutoclax + Azacitidine Versus Venetoclax + Azacitidine in Untreated Acute Myeloid Leukemia (AML) PatientsBeijing InnoCare Pharma Tech Co., Ltd. · not yet recruiting · Acute Myeloblastic Leukaemia · principal investigator
- Ph3NCT07407660 · Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus VenetoclaxPeking University People's Hospital · not yet recruiting · Acute Myeloid Leukemia · principal investigator
- N/ANCT07383298 · Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated PhaseQian Jiang · enrolling by invitation · Chronic Myeloid Leukemia · principal investigator
- Ph2NCT06453902 · TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) PatientsShenzhen TargetRx Co., Ltd. · recruiting · Chronic Myeloid Leukemia, Accelerated Phase CML · principal investigator
- N/ANCT06390306 · The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBPPeking University People's Hospital · recruiting · Chronic Myeloid Leukemia · principal investigator
- Ph1NCT05434312 · TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) PatientsShenzhen TargetRx Co., Ltd. · active not recruiting · Chronic Myelogenous Leukemia · principal investigator
- Ph1/Ph2NCT05309213 · Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic LeukemiaBeijing Immunochina Medical Science & Technology Co., Ltd. · unknown · Leukemia · principal investigator
- Ph1NCT03882281 · Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid LeukemiaAscentage Pharma Group Inc. · completed · Chronic Myeloid Leukemia, Chronic Phase · principal investigator
- Ph2NCT03883100 · A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I MutationAscentage Pharma Group Inc. · unknown · Chronic Myeloid Leukemia - Accelerated Phase · principal investigator
- Ph2NCT03883087 · A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I MutationAscentage Pharma Group Inc. · unknown · Chronic Myeloid Leukemia, Chronic Phase · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 23 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:51 UTC. The ranking covers the 200 most relevant of 294 PubMed records, and a shared surname and initials can bring in a namesake. All 294 on PubMed
- 1,475 citationsRCR 40.9
- Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.J Clin Oncol · 20101,149 citationsRCR 30.3
- 914 citationsRCR 26.3
- 653 citationsRCR 27.7
- Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.N Engl J Med · 2023574 citationsRCR 62.5
- Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies.Bone Marrow Transplant · 2006396 citationsRCR 9.6
- 179 citationsRCR 9.9
- Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancer.Cancer Discov · 2013177 citationsRCR 4.5
- Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer.Am J Transplant · 2012175 citationsRCR 5.5
- Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus.Clin Exp Pharmacol Physiol · 2014172 citationsRCR 6.3